Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of DNAJC9 mRNA | CTD | PMID:24763279 | 1,2-dimethylhydrazine | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of DNAJC9 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Dnajc9 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC9 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of DNAJC9 mRNA | CTD | PMID:20660070 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of DNAJC9 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of DNAJC9 mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DNAJC9 mRNA | CTD | PMID:34747641 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of DNAJC9 mRNA | CTD | PMID:21346803 | 2-palmitoylglycerol | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of DNAJC9 mRNA | CTD | PMID:37199045 | 3-methylcholanthrene | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of DNAJC9 mRNA | CTD | PMID:20713471 | 4-hydroxyphenyl retinamide | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Fenretinide results in increased expression of DNAJC9 mRNA | CTD | PMID:28973697 | 7,12-dimethyltetraphene | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:32553695 | aflatoxin B1 | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of DNAJC9 mRNA | CTD | PMID:19770486 | arsenous acid | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of DNAJC9 mRNA | CTD | PMID:15761015 | atazanavir sulfate | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Atazanavir Sulfate results in increased expression of DNAJC9 mRNA | CTD | PMID:32152650 | atrazine | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of DNAJC9 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Benzo(a)pyrene metabolite results in increased expression of DNAJC9 mRNA and Benzo(a)pyrene results in increased expression of DNAJC9 mRNA | CTD | PMID:19770486 more ... | benzo[a]pyrene | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of DNAJC9 mRNA | CTD | PMID:32234424 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | bis(2-chloroethyl) sulfide | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Mustard Gas results in decreased expression of DNAJC9 mRNA | CTD | PMID:25102026 | bisphenol A | decreases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of DNAJC9 mRNA | CTD | PMID:26063408 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DNAJC9 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of DNAJC9 gene | CTD | PMID:28505145 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DNAJC9 mRNA | CTD | PMID:25181051 and PMID:32145629 | buspirone | decreases expression | EXP | | 6480464 | Buspirone results in decreased expression of DNAJC9 mRNA | CTD | PMID:24136188 | cadmium atom | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC9 mRNA | CTD | PMID:35301059 | cadmium dichloride | affects methylation | EXP | | 6480464 | Cadmium Chloride affects the methylation of DNAJC9 promoter | CTD | PMID:22457795 | cadmium dichloride | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC9 mRNA | CTD | PMID:35301059 | calcitriol | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of DNAJC9 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of DNAJC9 mRNA | CTD | PMID:21592394 | carbamazepine | affects expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of DNAJC9 mRNA | CTD | PMID:24752500 | chenodeoxycholic acid | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | chlorpyrifos | decreases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of DNAJC9 mRNA | CTD | PMID:37019170 | cisplatin | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA] | CTD | PMID:21858171 | cisplatin | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Cisplatin results in increased expression of DNAJC9 mRNA | CTD | PMID:25270620 | copper(II) sulfate | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of DNAJC9 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | DNAJC9 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of DNAJC9 protein | CTD | PMID:35688186 | coumestrol | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of DNAJC9 mRNA | CTD | PMID:19167446 | crocidolite asbestos | decreases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of DNAJC9 mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of DNAJC9 mRNA | CTD | PMID:32152650 | cyclosporin A | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA | CTD | PMID:32152650 | deoxycholic acid | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | diarsenic trioxide | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of DNAJC9 mRNA | CTD | PMID:15761015 | dibutyl phthalate | decreases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of DNAJC9 mRNA | CTD | PMID:21266533 | diclofenac | affects expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Diclofenac affects the expression of DNAJC9 mRNA | CTD | PMID:24752500 | dicrotophos | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of DNAJC9 mRNA | CTD | PMID:28302478 | dioxygen | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of DNAJC9 mRNA | CTD | PMID:26516004 | doxorubicin | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of DNAJC9 mRNA | CTD | PMID:29803840 | elemental selenium | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Selenium results in decreased expression of DNAJC9 mRNA | CTD | PMID:19244175 | Enterolactone | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA | CTD | PMID:19167446 | enzyme inhibitor | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DNAJC9 protein | CTD | PMID:23301498 | folic acid | multiple interactions | ISO | Dnajc9 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC9 mRNA | CTD | PMID:22206623 | glycidyl methacrylate | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | glycidyl methacrylate results in increased expression of DNAJC9 protein | CTD | PMID:36641056 | glycochenodeoxycholic acid | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | glycocholic acid | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | glycodeoxycholic acid | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 | ivermectin | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of DNAJC9 protein | CTD | PMID:32959892 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of DNAJC9 mRNA | CTD | PMID:24136188 | levofloxacin | decreases expression | EXP | | 6480464 | Levofloxacin results in decreased expression of DNAJC9 mRNA | CTD | PMID:24136188 | methyl methanesulfonate | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of DNAJC9 mRNA | CTD | PMID:23649840 | mitomycin C | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Mitomycin results in increased expression of DNAJC9 mRNA | CTD | PMID:25270620 | N-nitrosodiethylamine | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of DNAJC9 mRNA | CTD | PMID:17854601 | N-nitrosodiethylamine | multiple interactions | ISO | Dnajc9 (Mus musculus) | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DNAJC9 mRNA] | CTD | PMID:17854601 | niclosamide | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Niclosamide results in decreased expression of DNAJC9 mRNA | CTD | PMID:36318118 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of DNAJC9 mRNA | CTD | PMID:25729387 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of DNAJC9 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Dnajc9 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DNAJC9 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Acetaminophen affects the expression of DNAJC9 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of DNAJC9 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of DNAJC9 mRNA | CTD | PMID:22230336 | perfluorohexanesulfonic acid | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of DNAJC9 mRNA | CTD | PMID:37995155 | perfluorooctanoic acid | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of DNAJC9 protein | CTD | PMID:26879310 | phenobarbital | affects expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Phenobarbital affects the expression of DNAJC9 mRNA | CTD | PMID:23091169 | pirinixic acid | multiple interactions | ISO | Dnajc9 (Mus musculus) | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of DNAJC9 mRNA] | CTD | PMID:21318169 | pirinixic acid | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of DNAJC9 mRNA | CTD | PMID:18301758 more ... | piroxicam | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA] | CTD | PMID:21858171 | piroxicam | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Piroxicam results in increased expression of DNAJC9 mRNA | CTD | PMID:21858171 | progesterone | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of DNAJC9 mRNA | CTD | PMID:20660070 | resveratrol | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA | CTD | PMID:19167446 | SB 431542 | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJC9 protein | CTD | PMID:37664457 | selenium atom | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Selenium results in decreased expression of DNAJC9 mRNA | CTD | PMID:19244175 | sodium fluoride | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of DNAJC9 protein | CTD | PMID:28918527 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of DNAJC9 mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of DNAJC9 mRNA | CTD | PMID:31533062 | Sunset Yellow FCF | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA | CTD | PMID:33819548 | tartrazine | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA | CTD | PMID:33819548 | testosterone | multiple interactions | ISO | DNAJC9 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of DNAJC9 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of DNAJC9 mRNA | CTD | PMID:21592394 | tetrachloromethane | increases expression | ISO | Dnajc9 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of DNAJC9 mRNA | CTD | PMID:27339419 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of DNAJC9 mRNA | CTD | PMID:25729387 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of DNAJC9 mRNA | CTD | PMID:33387578 | uranium atom | affects expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Uranium affects the expression of DNAJC9 mRNA | CTD | PMID:15672453 | valproic acid | increases expression | ISO | DNAJC9 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of DNAJC9 mRNA | CTD | PMID:23179753 | |